Revvity Lowers FY2026 Adj EPS Guidance from $5.35-$5.45 to $5.20-$5.30 vs $5.39 Est; Lowers FY2026 Sales Guidance from $2.960B-$2.990B to $2.810B-$2.840B vs $2.977B Est.

Benzinga Newsdesk www.benzinga.com Negative 95.1%

Neg 95.1% Neu 0% Pos 0%

Revvity (NYSE:RVTY) lowers FY2026 Adj EPS guidance from $5.35-$5.45 to $5.20-$5.30 vs $5.39 analyst estimate. Lowers FY2026 sales outlook from $2.960 billion-$2.990 billion to $2.810 billion-$2.840 billion vs $2.977 billion estimate.